Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

QUIBRON-T

THEOPHYLLINE

Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview QUIBRON-T is listed in Drugs@FDA under application 088656 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET;ORAL - 300MG Sponsor MONARCH PHARMS Submission history Latest submission status date: 1997-06-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview QUIBRON-T is listed in Drugs@FDA under application 088656 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET;ORAL - 300MG Sponsor MONARCH PHARMS Submission history Latest submission status date: 1997-06-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
QUIBRON-T (THEOPHYLLINE) | Drug Monograph | MedicHelpline